Rocket Doctor Engages Danayi Capital for Digital Marketing Services

Rhea-AI Summary

Rocket Doctor AI (OTC: AIRDF) engaged Danayi Capital for a two-month digital marketing contract starting Feb 9, 2026 for an up-front fee of USD 125,000. Danayi will run online advertising via wallstreetlogic.com and holds no current interest in the company.

The company also granted 33,353 stock options exercisable at $0.77 for three years and 205,065 restricted share units valid for three years; both awards vest over one year and are issued under the company’s share compensation plans.

Vancouver, BC, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that it has engaged Danayi Capital Corp. (“Danayi”) to provide digital marketing services for a two (2) month term commencing on February 9, 2026, in consideration of an up-front payment of USD$125,000.

Danayi shall utilize digital marketing and online advertisements through www.wallstreetlogic.com.  Danayi does not currently own any interest, directly or indirectly, in the Company or its securities. Danayi’s address is 550-800 West Pender Street, Vancouver, BC, V6C 2V6 (phone: (604) 767-2983, email: mehran@danayi.co). Danayi and its directors and officers are arm’s length from the Company.

Further, the Company announces that it has granted an aggregate 33,353 stock options, exercisable at $0.77 per share and valid for a term of three years, and an aggregate 205,065 restricted share units, valid for a term of three years, to consultants of the Company.  The stock options and restricted share units are issued pursuant to the Company’s share compensation plans and are subject to vesting over one year.

About Rocket Doctor AI Inc.

Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.

By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.

To learn more about Rocket Doctor AI Inc’s products and services, contact:

www.rocketdoctor.ai  or email: info@rocketdoctor.ai

FOR ADDITIONAL INFORMATION, CONTACT:

Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321

Cautionary Statements

This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this releaseare forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

FAQ

What digital marketing services did Rocket Doctor AI (AIRDF) engage Danayi Capital to provide?

Rocket Doctor AI engaged Danayi Capital for two months of digital marketing starting February 9, 2026. According to the company, Danayi will deliver online advertising and digital marketing through wallstreetlogic.com for an up-front fee of USD 125,000.

How long is the Danayi Capital engagement and what is the cost for AIRDF?

The engagement runs for two months beginning February 9, 2026 and costs USD 125,000 up front. According to the company, the payment is an up-front consideration for digital marketing services delivered during the term.

What equity compensation did Rocket Doctor AI grant to consultants as announced on January 30, 2026?

The company granted 33,353 stock options and 205,065 restricted share units to consultants. According to the company, options are exercisable at $0.77 and all awards vest over one year with three-year terms.

Are Danayi Capital or its directors shareholders of Rocket Doctor AI (AIRDF)?

No, Danayi Capital does not currently own any interest in Rocket Doctor AI or its securities. According to the company, Danayi and its directors and officers are arm’s length from the company.

Where will Danayi publish the online advertisements for the AIRDF marketing campaign?

Danayi will utilize digital marketing and online advertisements through wallstreetlogic.com. According to the company, that website is the specified channel for the contracted online advertising during the two-month term.